| 000 | 01509 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515115351.0 | ||
| 264 | 0 | _c20080915 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/CAD.0b013e3282fdc391 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarabas, Karri | |
| 245 | 0 | 0 |
_aHyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cJun 2008 |
||
| 300 |
_a495-502 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBilirubin _xblood |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aHyperbilirubinemia _xmetabolism |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Gunn |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aMilner, Rowan | |
| 700 | 1 | _aFarese, James | |
| 700 | 1 | _aBaylis, Chris | |
| 700 | 1 | _aCroker, Byron | |
| 700 | 1 | _aArcher, Linda | |
| 700 | 1 | _aAdin, Christopher | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 19 _gno. 5 _gp. 495-502 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0b013e3282fdc391 _zAvailable from publisher's website |
| 999 |
_c17916044 _d17916044 |
||